Vivimed Labs reports Profit after tax of Rs -221.55 Mln, in the September 2022 quarter

21 Nov 2022 Evaluate
The sales for the September 2022 quarter moved down to Rs. 391.82 millions as compared to Rs. 510.44 millions during the year-ago period.The Net Loss for the quarter ended September 2022 is Rs. -221.55 millions as compared to Net Loss of Rs. -234.59 millions of corresponding quarter ended September 2021 Operating profit Margin for the quarter ended September 2022 improved to -95.61% as compared to -107.43% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 391.82 510.44 -23.24 865.46 1133.42 -23.64 2183.67 2100.46 3.96
Other Income 1.49 1.43 4.20 2.30 10.58 -78.26 12.59 60.75 -79.28
PBIDT -95.61 -107.43 -11.00 -180.09 9.91 -1917.26 -79.58 278.64 -128.56
Interest 87.90 85.50 2.81 180.47 179.96 0.28 395.27 414.92 -4.74
PBDT -183.51 -192.93 -4.88 -360.56 -170.05 112.03 -474.85 -136.28 248.44
Depreciation 38.04 41.66 -8.69 80.37 85.17 -5.64 174.50 157.95 10.48
PBT -221.55 -234.59 -5.56 -440.93 -255.22 72.76 -649.35 -294.23 120.69
TAX 0.00 0.00 0.00 -0.52 0.00 0.00 28.17 -2.34 -1303.85
Deferred Tax 0.00 0.00 0.00 -0.52 0.00 0.00 28.17 0.00 0.00
PAT -221.55 -234.59 -5.56 -440.41 -255.22 72.56 -677.52 -291.89 132.11
Equity 165.83 165.83 0.00 165.83 165.83 0.00 165.83 165.83 0.00
PBIDTM(%) -24.40 -21.05 15.94 -20.81 0.87 -2480.03 -3.64 13.27 -127.47

Vivimed Labs Share Price

5.75 0.00 (0.00%)
31-Jul-2023 18:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×